Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay
- PMID: 17360857
- PMCID: PMC1865626
- DOI: 10.1128/CVI.00368-06
Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay
Abstract
Given the recent report of a false-positive result in the Platelia Aspergillus enzyme immunoassay in a patient with cryptococcosis and in yeast extracts and purified galactoxylomannan of Cryptococcus neoformans, we evaluated culture extracts, purified polysaccharides, clinical specimens, and specimens from animals following experimental infection. Our results revealed no cross-reactions.
Figures

Similar articles
-
Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):735-741. doi: 10.1007/s10096-019-03469-3. Epub 2019 Jan 25. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30684164
-
Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan.J Clin Microbiol. 2005 Jun;43(6):2929-31. doi: 10.1128/JCM.43.6.2929-2931.2005. J Clin Microbiol. 2005. PMID: 15956422 Free PMC article.
-
Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.Diagn Immunol. 1984;2(2):109-15. Diagn Immunol. 1984. PMID: 6388977
-
An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan.Res Immunol. 1990 Jan;141(1):33-42. doi: 10.1016/0923-2494(90)90099-k. Res Immunol. 1990. PMID: 2189167
-
Characteristics of immunity in fungal infections.Am J Vet Res. 1975 Apr;36(4 Pt 2):601-2. Am J Vet Res. 1975. PMID: 1092228 Review. No abstract available.
Cited by
-
Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):735-741. doi: 10.1007/s10096-019-03469-3. Epub 2019 Jan 25. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30684164
-
Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1.Med Mycol. 2008 Mar;46(2):153-62. doi: 10.1080/13693780701747182. Med Mycol. 2008. PMID: 18324494 Free PMC article.
-
Virulence factors released by extracellular vesicles from Cryptococcus neoformans.Front Cell Infect Microbiol. 2025 May 14;15:1572520. doi: 10.3389/fcimb.2025.1572520. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40438241 Free PMC article. Review.
-
Cross-reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus species in the commercial Platelia Aspergillus enzyme immunoassay.Clin Vaccine Immunol. 2009 Jan;16(1):132-3. doi: 10.1128/CVI.00310-08. Epub 2008 Nov 19. Clin Vaccine Immunol. 2009. PMID: 19020109 Free PMC article.
-
Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis.Clin Vaccine Immunol. 2008 Jul;15(7):1095-105. doi: 10.1128/CVI.00068-08. Epub 2008 May 7. Clin Vaccine Immunol. 2008. PMID: 18463222 Free PMC article.
References
-
- Chaka, W., A. F. Verheul, V. V. Vaishnav, R. Cherniak, J. Scharringa, J. Verhoef, H. Snippe, and A. I. Hoepelman. 1997. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J. Immunol. 159:2979-2985. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources